University of Sydney unveils its new medical imaging facility
The University of Sydney has launched its new medical imaging facility. Named Sydney Imaging, the facility will support researchers within medical research through the use of imaging technology.
Sydney Imaging’s Hybrid Theatre also houses a number of technologies, ranging from biomedical imaging and AI, to robotics which support surgical training, the University has stated.
Through the use of imaging technology, researchers will be gain the ability to explore chronic diseases through non-invasive methods and support long-term patient care. The term “hybrid” signals a transformation on how surgeries are undertaken – a mix of traditional open surgeries and minimally invasive procedures.
- Google partners with the American Medical Association to promote data sharing
- Digitally enhancing the patient experience
- How accessible 3D printing can improve quality of life
“Researchers will be able to easily combine magnetic resonance imaging with X-ray and ultrasound systems, greatly increasing the range of procedures they can undertake. We are also exploring how surgical robotics might interact this technology, and are working with experts at the University’s Australian Centre for Field Robotics to develop new applications in surgery and medicine,” explained Academic Director of Core Research Facilities Professor Simon Ringer.
Utilising Australia’s first advanced robotic imaging system, the ARTIS pheno C-Arm, the Hybrid Theatre also houses enhanced cameras in the rooms, as well as video conferencing to support its research capabilities.
“This initiative offers a valuable opportunity for the local health community to strengthen connections with existing collaborators and foster new partnerships – in order to advance scientific and medical discoveries and ensure our healthcare system remains fit for future purpose,” added Executive Director of Sydney Health Partners, Professor Garry Jennings.
Jvion launches AI-powered map to tackle mental health crisis
Clinical AI company Jvion has launched an interactive map of the US that highlights areas that are most vulnerable to poor mental health.
The Behavioral Health Vulnerability Map uses Jvion's AI CORE™ software to analyse public data on social determinants of health (SDOH) and determine the vulnerability of every US Census block group.
Vulnerability refers to the likelihood that residents will experience issues like self-harm, suicide attempts or overdoses. The map also identifies the most influential social determinants in each region, to show the social and environmental conditions that contribute to mental illness.
As an example, the map shows that Harrison County in Mississippi has a 50% higher suicide rate than the rest of the state. It also shows a high percentage of individuals in the armed forces at a time when active duty suicides are at a six-year high, along with a high prevalence of coronary artery disease, arthritis, and COPD, all chronic illnesses that are linked to a higher suicide risk.
The map also shows Harrison County has a high percentage of Vietnamese Americans, who studies suggest have high rates of depression and may be less likely to seek help from mental health professionals.
The map was built using the same data and analytics that Jvion used to create the COVID Community Vulnerability Map, which was launched towards the start of the pandemic.
With this new map, Jvion is aiming to tackle the growing mental health crisis in the US. “At a time when so many Americans are struggling with their mental health, we’re proud to offer a tool that can help direct treatment resources to the communities that need it most,” said Dr John Showalter, MD, Jvion’s chief product officer, who led the development of the map.
“For too long, the healthcare industry has struggled to address social determinants of health, particularly in the context of behavioural health. Our hope is that by surfacing the social and environmental vulnerabilities of America’s communities, we can better coordinate our response to the underlying conditions that impact the health and wellbeing of people everywhere.”